Community-level responses and environmental fate of metformin in freshwater mesocosms.

Fuente: PubMed
Salvato in:
Dettagli Bibliografici
Autori principali: Blandford, Nicholas C, Palace, Vince, Rodríguez-Gil, José Luis, Timlick, Lauren, Stanley, Madeline, Frank, Richard A, Campbell, Sheena, Rudy, Martina, Marshall, Stephanie, Wynia, Abby, Clark, Thomas, Cunningham, Jessie, Alaee, Mehran, Parrott, Joanne, Kidd, Karen A, Stevack, Kathleen, Sabourin, Lyne, Renaud, Justin B, Sumarah, Mark W, Nielsen, Kristin, McMaster, Mark E, Ussery, Erin
Natura: Artículo científico
Lingua:en
Pubblicazione: The Science of the total environment 2024
Soggetti:
Accesso online:
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1868266277695389697
author Blandford, Nicholas C
Palace, Vince
Rodríguez-Gil, José Luis
Timlick, Lauren
Stanley, Madeline
Frank, Richard A
Campbell, Sheena
Rudy, Martina
Marshall, Stephanie
Wynia, Abby
Clark, Thomas
Cunningham, Jessie
Alaee, Mehran
Parrott, Joanne
Kidd, Karen A
Stevack, Kathleen
Sabourin, Lyne
Renaud, Justin B
Sumarah, Mark W
Nielsen, Kristin
McMaster, Mark E
Ussery, Erin
author_facet Blandford, Nicholas C
Palace, Vince
Rodríguez-Gil, José Luis
Timlick, Lauren
Stanley, Madeline
Frank, Richard A
Campbell, Sheena
Rudy, Martina
Marshall, Stephanie
Wynia, Abby
Clark, Thomas
Cunningham, Jessie
Alaee, Mehran
Parrott, Joanne
Kidd, Karen A
Stevack, Kathleen
Sabourin, Lyne
Renaud, Justin B
Sumarah, Mark W
Nielsen, Kristin
McMaster, Mark E
Ussery, Erin
Blandford, Nicholas C
Palace, Vince
Rodríguez-Gil, José Luis
Timlick, Lauren
Stanley, Madeline
Frank, Richard A
Campbell, Sheena
Rudy, Martina
Marshall, Stephanie
Wynia, Abby
Clark, Thomas
Cunningham, Jessie
Alaee, Mehran
Parrott, Joanne
Kidd, Karen A
Stevack, Kathleen
Sabourin, Lyne
Renaud, Justin B
Sumarah, Mark W
Nielsen, Kristin
McMaster, Mark E
Ussery, Erin
collection PubMed - marine biology
contents Community-level responses and environmental fate of metformin in freshwater mesocosms. Blandford, Nicholas C Palace, Vince Rodríguez-Gil, José Luis Timlick, Lauren Stanley, Madeline Frank, Richard A Campbell, Sheena Rudy, Martina Marshall, Stephanie Wynia, Abby Clark, Thomas Cunningham, Jessie Alaee, Mehran Parrott, Joanne Kidd, Karen A Stevack, Kathleen Sabourin, Lyne Renaud, Justin B Sumarah, Mark W Nielsen, Kristin McMaster, Mark E Ussery, Erin Metformin Water Pollutants, Chemical Environmental Monitoring Animals Daphnia Phytoplankton Ontario Zooplankton Lakes Fresh Water Ecosystem The type 2 diabetes drug metformin is among the most frequently prescribed, dispensed, and consumed pharmaceuticals worldwide; and its heavy use and poor breakdown means it is consequently detected in various wastewater treatment plant (WWTP) effluents and surface waters. The resulting environmental concentrations of metformin can have adverse impacts on aquatic ecosystems. An 8-week in-lake mesocosm experiment was conducted in a freshwater boreal lake at the IISD-Experimental Lakes Area (Ontario, Canada) to determine the environmental fate and effects of metformin. Mesocosms were assigned to nominal concentrations of 0, 5, or 50 μg L metformin, in replicates of four. Biotic communities (i.e. microbial, phytoplankton, zooplankton, benthic macroinvertebrate) were assessed and complementary Lemna gibba and Daphnia magna bioassays were conducted in the laboratory. Metformin was extremely stable during the 8-week experiment, with mean measured concentrations of 0.00, 5.42, and 42.79 μg L in mesocosm surface waters for the 0, 5, and 50 μg L treatments, respectively. While trace amounts of metformin were detected in mesocosm sediments, the compound was primarily found in the water column. After over 1 year following metformin additions, the mean loss of metformin from surface water was 94.0 % and 91.0 % for the 5 and 50 μg L treatment groups, respectively. No adverse effects of metformin treatment on the diversity, abundance, or biomass of microbial, phytoplankton, zooplankton, or benthic macroinvertebrate communities were found. Additionally, no survival or reproductive effects were observed in the 21-d Daphnia magna bioassays and no significant effects were observed in the 7-d Lemna gibba growth assays. No substantial metformin transformation to guanylurea was observed in mesocosm surface waters or sediments, likely due to a lack of bacterial degradation occurring within mesocosms relative to WWTPs.
format Artículo científico
id pubmed_39566626
institution PubMed
language en
publishDate 2024
publisher The Science of the total environment
record_format pubmed
spellingShingle Community-level responses and environmental fate of metformin in freshwater mesocosms.
Blandford, Nicholas C
Palace, Vince
Rodríguez-Gil, José Luis
Timlick, Lauren
Stanley, Madeline
Frank, Richard A
Campbell, Sheena
Rudy, Martina
Marshall, Stephanie
Wynia, Abby
Clark, Thomas
Cunningham, Jessie
Alaee, Mehran
Parrott, Joanne
Kidd, Karen A
Stevack, Kathleen
Sabourin, Lyne
Renaud, Justin B
Sumarah, Mark W
Nielsen, Kristin
McMaster, Mark E
Ussery, Erin
Metformin
Water Pollutants, Chemical
Environmental Monitoring
Animals
Daphnia
Phytoplankton
Ontario
Zooplankton
Lakes
Fresh Water
Ecosystem
Community-level responses and environmental fate of metformin in freshwater mesocosms. Blandford, Nicholas C Palace, Vince Rodríguez-Gil, José Luis Timlick, Lauren Stanley, Madeline Frank, Richard A Campbell, Sheena Rudy, Martina Marshall, Stephanie Wynia, Abby Clark, Thomas Cunningham, Jessie Alaee, Mehran Parrott, Joanne Kidd, Karen A Stevack, Kathleen Sabourin, Lyne Renaud, Justin B Sumarah, Mark W Nielsen, Kristin McMaster, Mark E Ussery, Erin Metformin Water Pollutants, Chemical Environmental Monitoring Animals Daphnia Phytoplankton Ontario Zooplankton Lakes Fresh Water Ecosystem The type 2 diabetes drug metformin is among the most frequently prescribed, dispensed, and consumed pharmaceuticals worldwide; and its heavy use and poor breakdown means it is consequently detected in various wastewater treatment plant (WWTP) effluents and surface waters. The resulting environmental concentrations of metformin can have adverse impacts on aquatic ecosystems. An 8-week in-lake mesocosm experiment was conducted in a freshwater boreal lake at the IISD-Experimental Lakes Area (Ontario, Canada) to determine the environmental fate and effects of metformin. Mesocosms were assigned to nominal concentrations of 0, 5, or 50 μg L metformin, in replicates of four. Biotic communities (i.e. microbial, phytoplankton, zooplankton, benthic macroinvertebrate) were assessed and complementary Lemna gibba and Daphnia magna bioassays were conducted in the laboratory. Metformin was extremely stable during the 8-week experiment, with mean measured concentrations of 0.00, 5.42, and 42.79 μg L in mesocosm surface waters for the 0, 5, and 50 μg L treatments, respectively. While trace amounts of metformin were detected in mesocosm sediments, the compound was primarily found in the water column. After over 1 year following metformin additions, the mean loss of metformin from surface water was 94.0 % and 91.0 % for the 5 and 50 μg L treatment groups, respectively. No adverse effects of metformin treatment on the diversity, abundance, or biomass of microbial, phytoplankton, zooplankton, or benthic macroinvertebrate communities were found. Additionally, no survival or reproductive effects were observed in the 21-d Daphnia magna bioassays and no significant effects were observed in the 7-d Lemna gibba growth assays. No substantial metformin transformation to guanylurea was observed in mesocosm surface waters or sediments, likely due to a lack of bacterial degradation occurring within mesocosms relative to WWTPs.
title Community-level responses and environmental fate of metformin in freshwater mesocosms.
topic Metformin
Water Pollutants, Chemical
Environmental Monitoring
Animals
Daphnia
Phytoplankton
Ontario
Zooplankton
Lakes
Fresh Water
Ecosystem
url https://pubmed.ncbi.nlm.nih.gov/39566626/